<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03634722</url>
  </required_header>
  <id_info>
    <org_study_id>PKUPH2</org_study_id>
    <nct_id>NCT03634722</nct_id>
  </id_info>
  <brief_title>The Efficacy of Transcutaneous Electrical Nerve Stimulation on LUTS: One Prospective Study.</brief_title>
  <official_title>Beijing Key Laboratory of Female Pelvic Floor Disorders of Peking University People's Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective study at a single institution. Investigators create strict
      inclusion and exclusion criteria, selecting 126 patients who undergo the pelvic
      reconstructive surgery. 63 patients in the intervention group accept 10 times of the
      transcutaneous electrical nerve stimulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the patients have severe pelvic organ prolapse and undergo the pelvic reconstructive
      surgery. Investigators evaluate all patients' lower urinary tract symptoms, quality of life
      score, overactive bladder questionnaire, maximal rate and residual urine volume, at 1, 3, 6
      and 12 months after the surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 11, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 7, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>the transcutaneous electrical nerve stimulation by PHENIX4-8-8 PLUS</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the rate of urinary retention</measure>
    <time_frame>three days after surgery</time_frame>
    <description>urinary residual volume</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the rate of urinary incontinence</measure>
    <time_frame>three days; seven days; one month; three months; six months after surgery</time_frame>
    <description>according to the 1-h pad test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>The intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the transcutaneous electrical nerve stimulation by PHENIX4-8-8 PLUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The observational group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>routine nursing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PHENIX4-8-8 PLUS</intervention_name>
    <description>transcutaneous electrical nerve stimulation by PHENIX4-8-8 PLUS</description>
    <arm_group_label>The intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severe pelvic organ prolapse(POP-Q:3/4 stage)

          -  accept pelvic reconstructive surgery

        Exclusion Criteria:

          -  Dominant stress urinary incontinence

          -  Serious medical problems

          -  mental disease

          -  infectious disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiuli Sun</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Key Laboratory of Female Pelvic Floor Disorders</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiuli Sun, professor</last_name>
    <phone>010-88324354</phone>
    <email>sunxiuli918@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Xiuli Sun, professor</last_name>
      <phone>010-88324354</phone>
      <email>sunxiuli918@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Tingting Cao, doctor</last_name>
      <phone>010-88324354</phone>
      <email>zzucaotingting@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>July 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2018</study_first_posted>
  <last_update_submitted>December 25, 2018</last_update_submitted>
  <last_update_submitted_qc>December 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transcutaneous electrical nerve stimulation;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The Transcutaneous Electrical Nerve Stimulation can decrease the rate of Lower Urinary Tract Symptoms after Pelvic Reconstructive Surgery</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>two years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

